Franklin Resources
BNTC icon

Franklin Resources’s Benitec Biopharma BNTC Stock Holding History

Franklin Resources’s Portfolio BNTC Stock Details BNTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$25.3M Buy
2,378,159
+180,854
+8% +$2.09M 0.01% 897
2025
Q4 		$29.6M Sell
2,197,305
-392,328
-15% -$5.43M 0.01% 832
2025
Q3 		$36.3M Sell
2,589,633
-111,810
-4% -$1.43M 0.01% 744
2025
Q2 		$31.6M Sell
2,701,443
-159,283
-6% -$2.23M 0.01% 779
2025
Q1 		$37.2M Sell
2,860,726
-78,561
-3% -$951K 0.01% 705
2024
Q4 		$37.1M Buy
2,939,287
+2,142,643
+269% +$23.1M 0.01% 706
2024
Q3 		$8.09M Hold
796,644
– – ﹤0.01% 1200
2024
Q2 		$5.57M Buy
796,644
+208,334
+35% +$1.54M ﹤0.01% 1274
2024
Q1 		$3.01M Buy
588,310
+73
+0% +$280 ﹤0.01% 1563
2023
Q4 		$1.91M Hold
588,237
– – ﹤0.01% 1408
2023
Q3 		$1.78M Buy
588,237
+2
+0% +$6 ﹤0.01% 1427
2023
Q2 		$2.38M Hold
588,235
– – ﹤0.01% 1346
2023
Q1 		$2.1M Hold
588,235
– – ﹤0.01% 1351
2022
Q4 		$1.7M Hold
588,235
– – ﹤0.01% 1409
2022
Q3 		$3.72M Buy
+588,235
New +$7.47M ﹤0.01% 1159

Other funds holding BNTC

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
IAM
Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

Franklin Resources's BNTC Position: Q1 2026 in Review

Franklin Resources increased its Benitec Biopharma (BNTC) stake by 8.2% in Q1 2026, buying an estimated $2.09M and bringing the position to 2,378,159 shares worth $25.3M. The position accounts for 0.01% of the portfolio, ranked #897.

Franklin Resources first reported a position in BNTC in Q3 2022 and has held it in 15 quarters since. The position peaked at $37.2M in Q1 2025. 88 funds tracked by Wall St. Rank hold BNTC as of Q1 2026.

  • Franklin Resources held 2,378,159 shares of Benitec Biopharma worth $25.3M as of Q1 2026.
  • Franklin Resources bought 180,854 Benitec Biopharma shares in Q1 2026, an estimated $2.09M.
  • Benitec Biopharma made up 0.01% of Franklin Resources's portfolio in Q1 2026, its #897 holding.
  • Franklin Resources first reported a position in Benitec Biopharma in Q3 2022 and has held it in 15 quarters since.
  • Franklin Resources's Benitec Biopharma position peaked at $37.2M in Q1 2025.
  • 88 funds tracked by Wall St. Rank held Benitec Biopharma as of Q1 2026.

Based on Franklin Resources's 13F filing for Q1 2026, filed 13 May 2026.